国产精品人人做人人爽,高潮毛片无遮挡高清免费,娇妻互换享受高潮

您好，歡迎來到拜力生物網站！請登錄注冊

我的訂單 | 聯系我們 | 在線客服QQ：3012681483 | 客服電話：400-968-7988 | 工作時間：08:30-17:30

主營產品： ELISA試劑盒、抗體、補體血清、兔補體、干擾素、小鼠測溫儀、進口試劑、Quidel代理、Swant代理、PBL Assay Science代理

網站首頁產品中心代理品牌新聞資訊資源中心關于我們

所在位置：首頁 > 產品中心 > Antibodies > Antibodies產品

訂購信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

Anti-CD45 Antibody

品牌：Antibodies

貨號：

規格：100μg

貨期：

應用：

咨詢客服

立即購買加入購物車

Anti-CD45 Antibody

商品詳情參考文獻相關資料

Overview

Name:	Anti-CD45 Antibody See all CD45 primary antibodies
Description:	Mouse monoclonal (MEM-28) antibody to CD45.
Specificity:	The antibody MEM-28 reacts with all alternative forms of human CD45 antigen (Leukocyte Common Antigen), a 180-220 kDa single chain type I transmembrane protein expressed at high level on all cells of hematopoietic origin, except erythrocytes and platelets.
Applications:	FC, IP, WB, IHC-P, ICC
Reactivity:	Human
Immunogen:	Human thymocytes and T lymphocytes.
Host:	Mouse
Clonality:	Monoclonal
Clone:	MEM-28
Isotype:	IgG1
Conjugate:	Unconjugated
Purification:	Protein A chromatography.
Concentration:	1 mg/ml
Purity:	> 95% (by SDS-PAGE)
Product Form:	Liquid
Formulation:	Supplied in Phosphate Buffered Saline, pH 7.4, with 15mM Sodium Azide.
Storage:	Store at 2-8°C.

Target

Function:	Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity (By similarity).
Involvement in Disease:	Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. Multiple sclerosis: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease.
Sequence Similarities:	Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Post-Translational Modification:	Heavily N- and O-glycosylated.
Cellular Location:	Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.
Database Links:	Entrez Gene: 5788?Human Omim: 151460?Human SwissProt: P08575?Human Unigene: 654514?Human
Synonyms:	B220 Antibody CD 45 Antibody CD45 Antibody CD45 antigen Antibody CD45R Antibody GP180 Antibody L-CA Antibody LCA Antibody Leukocyte common antigen Antibody loc Antibody Ly-5 Antibody LY5 Antibody Ly5, homolog of Antibody Lyt-4 Antibody OTTHUMP00000033813 Antibody OTTHUMP00000033816 Antibody OTTHUMP00000033817 Antibody OTTHUMP00000038574 Antibody Protein tyrosine phosphatase receptor type c polypeptide Antibody Protein tyrosine phosphatase, receptor type C Antibody protein tyrosine phosphatase, receptor type, C Antibody Protein tyrosine phosphatase, receptor type, c polypeptide Antibody Ptprc Antibody PTPRC_HUMAN Antibody Receptor-type tyrosine-protein phosphatase C Antibody T200 Antibody T200 glycoprotein Antibody T200 leukocyte common antigen Antibody
Information:	Target information shown above is from the UniProt Consortium.